acut
respiratori
tract
infect
major
caus
morbid
mortal
repres
signific
burden
health
care
system
laboratori
test
requir
definit
distinguish
infect
influenza
viru
pathogen
result
prolong
emerg
depart
ed
visit
unnecessari
antibiot
use
recent
avail
rapid
pointofcar
test
poct
may
allow
appropri
use
antivir
antibiot
treatment
decreas
patient
length
stay
undertook
systemat
review
assess
effect
poct
influenza
three
outcom
antivir
prescript
antibiot
prescript
patient
length
stay
ed
databas
medlin
embas
search
use
mesh
term
keyword
influenza
poct
antivir
antibiot
length
stay
amongst
studi
screen
includ
major
paper
report
antivir
prescript
found
posit
poct
result
significantli
increas
use
antivir
influenza
compar
neg
poct
result
standard
support
care
posit
poct
result
also
led
decreas
antibiot
use
result
studi
assess
effect
poct
ed
length
stay
definit
studi
assess
systemat
review
support
use
poct
diagnosi
influenza
patient
suffer
acut
respiratori
infect
diagnosi
use
poct
may
lead
appropri
prescript
treatment
infecti
agent
studi
need
assess
effect
poct
length
stay
ed
keyword
influenza
point
care
systemat
review
acut
respiratori
tract
infect
major
caus
morbid
mortal
repres
signific
burden
health
care
system
laboratori
test
requir
definit
distinguish
infect
influenza
viru
pathogen
result
prolong
emerg
depart
ed
visit
unnecessari
antibiot
use
recent
avail
rapid
pointofcar
test
poct
may
allow
appropri
use
antivir
antibiot
treatment
decreas
patient
length
stay
undertook
systemat
review
assess
effect
poct
influenza
three
outcom
antivir
prescript
approxim
death
annual
current
refer
standard
laboratori
test
influenza
diagnosi
quantit
revers
transcript
pcr
viral
cultur
uncommon
time
consum
expens
requir
specif
train
oper
new
rapid
diagnost
test
forinfluenza
avail
show
sensit
specif
compar
realtim
pcr
assay
figur
aim
systemat
review
literatur
determin
effect
pointofcar
test
influenza
outcom
patient
includ
use
antivir
influenza
viru
exp
point
care
system
mesh
rapid
test
ridt
radt
influenza
rapid
test
search
term
antivir
exp
antivir
agent
mesh
oseltamivir
mesh
antivir
ther
antibiot
use
search
term
exp
antibacteri
agent
mesh
antibiot
antibacteri
search
term
use
length
stay
exp
length
stay
mesh
lo
two
review
gw
ssb
independ
screen
titl
abstract
articl
elig
use
criteria
supplement
addit
paper
search
manual
use
refer
suitabl
articl
case
uncertainti
elig
relev
particular
articl
resolut
achiev
consensu
review
exclud
scientif
review
articl
commentari
cochran
review
case
studi
case
seri
studi
analyt
model
studi
confer
abstract
studi
involv
survey
studi
publish
english
consid
studi
elig
inclus
assess
effect
poct
clinic
manag
patient
present
physician
hospit
acut
medic
centr
hous
visit
influenzalik
ill
ili
review
poct
defin
commerci
avail
diagnost
assay
detect
influenza
respiratori
figur
generalis
step
differ
method
diagnost
test
influenza
poc
point
care
poct
point
care
test
rtqpcr
quantit
revers
transcript
pcr
sampl
test
consid
poct
need
conduct
immedi
specimen
acquisit
studi
specifi
test
perform
exclud
presum
done
point
care
test
commerci
avail
use
routin
influenza
diagnosi
enzymelink
immunosorb
assay
serolog
includ
definit
studi
use
refer
standard
viral
cell
cultur
nucleic
acid
test
immunofluoresc
diagnosi
base
patient
symptom
sign
elig
systemat
review
paper
exclud
result
poct
withheld
health
care
profession
use
diagnosi
attempt
made
contact
author
inform
data
lack
order
construct
tabl
search
perform
two
investig
separ
gw
ssb
qualiti
data
assess
two
investig
accord
oxford
centr
evidencebas
medicin
ocebm
guidelin
paper
includ
systemat
review
elig
grade
level
ocebm
level
evid
consid
level
studi
excel
qualiti
level
good
level
fair
result
databas
search
yield
public
remov
duplic
figur
titl
abstract
screen
paper
assess
elig
addit
studi
found
citat
relev
public
assess
paper
full
text
assess
studi
method
outcom
total
met
select
criteria
includ
systemat
review
use
ocebm
level
evid
tabl
nine
studi
grade
level
excel
qualiti
grade
level
good
qualiti
nine
grade
level
fair
qualiti
tabl
found
support
inform
result
studi
differ
level
evid
examin
qualit
similar
trend
observ
studi
includ
studi
consist
retrospect
prospect
public
measur
effect
poct
antivir
prescript
tabl
report
increas
antivir
use
associ
posit
diagnosi
poct
recent
randomis
control
trial
brendish
et
al
twentysix
studi
assess
effect
poct
antibiot
prescript
rate
nine
studi
assess
effect
poct
ed
length
stay
tabl
five
report
signific
reduct
time
spent
ed
associ
poct
use
patient
randomli
receiv
either
poct
n
standard
care
n
follow
nasopharyng
swap
taken
laboratori
confirm
sri
lanka
prospect
two
phase
studi
outpati
depart
sri
lankan
hospit
first
phase
mardec
patient
attend
physician
awar
poct
result
n
attribut
longer
ed
stay
significantli
older
age
poct
cohort
may
comorbid
whilst
reason
studi
unclear
emerg
depart
lo
influenc
mani
factor
includ
avail
bed
overcrowd
admiss
discharg
procedur
effici
ed
staff
thu
may
benefit
poct
term
ed
lo
somewhat
diminish
reflect
mix
find
public
systemat
review
nonetheless
studi
find
reduc
ed
stay
associ
poct
encourag
lead
improv
clinic
outcom
prevent
nosocomi
spread
eas
burden
healthcar
system
signific
reduct
ed
lo
like
establish
monitor
health
care
centr
becom
familiar
poc
technolog
earli
antigenbas
poc
test
poor
term
sensit
quikvu
influenza
test
sensit
neg
predict
valu
physician
mani
case
awar
limit
use
confirmatori
test
avoid
falseneg
result
nonetheless
find
studi
systemat
review
suggest
antigenbas
poct
still
significantli
affect
clinic
decisionmak
patient
outcom
newer
molecularbas
poct
boast
high
sensit
specif
mean
result
trust
physician
studi
use
newer
molecular
poct
saw
limit
effect
antibiot
prescript
rate
one
group
suggest
mani
case
antibiot
administ
earli
patient
assess
even
poct
result
avail
outcom
measur
proport
patient
treat
brief
cours
antibiot
may
clinic
relev
case
time
molecular
poct
perform
research
investig
rather
clinic
staff
suggest
studi
protocol
ini
systemat
review
thoroughli
check
two
studi
declar
potenti
conflict
interest
financi
support
commerci
manufactur
poct
three
other
disclos
profession
relationship
contribut
author
compani
limit
systemat
review
focu
restrict
influenza
diagnosi
antivir
antibiot
lo
outcom
whilst
outcom
highli
applic
influenza
manag
new
molecular
poct
filmarray
respiratori
panel
test
rang
virus
bacteria
simultan
henc
technolog
potenti
affect
variabl
cover
review
area
may
target
futur
research
past
decad
numer
studi
report
divers
use
nanoparticl
poct
receiv
great
interest
uniqu
chemic
physic
properti
sever
research
group
propos
simpl
colorimetr
approach
base
control
assembl
gold
nanoparticl
surfac
virus
includ
influenza
limit
detect
propos
method
time
lower
convent
enzymelink
immunosorb
assay
list
year
public
alphabet
b
also
assess
antivir
prescript
tabl
c
also
assess
antibiot
prescript
tabl
